| Model Number |
FX212T |
| Medical Device Problem Code |
Infusion or Flow Problem (2964)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
09/01/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Investigation: visual inspection: during the investigation, visible deposits in the outlet spout was determined.Permeability test: a permeability test has indicated that the valve has a blockage.Internal inspection: after dismantling of the valve, visible deposits were found in gav 2.0.Results: based on our investigation results, we can determine a blockage in the valve.The determined deposits can be named as the cause for the under-drainage.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
| |
|
Event or Problem Description
|
|
It was reported that a gav 2.0 (#fx212t) was implanted during a procedure performed on (b)(6) 2023.According to the complainant, the valve was believed to be operated in underdrainage.The patient underwent a revision procedure.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 2 years.Weight: 12 kilograms.Gender: male.
|
| |
|
Search Alerts/Recalls
|